{"slug":"toxicity","tag":"toxicity","variants":["toxicity"],"description":"No description yet","count":2,"kinds":{"person":2},"related":[{"slug":"geriatric-oncology","tag":"geriatric-oncology","shared":1},{"slug":"immunotherapy","tag":"immunotherapy","shared":1},{"slug":"melanoma","tag":"melanoma","shared":1},{"slug":"supportive-care","tag":"supportive-care","shared":1}],"records":[{"id":"michael-postow","kind":"person","name":"Michael A. Postow","route":"/people/michael-postow/","tldr":"Led CheckMate 069, the first randomised trial of nivolumab plus ipilimumab, and defines how to manage immunotherapy side effects."},{"id":"supriya-mohile","kind":"person","name":"Supriya G. Mohile","route":"/people/supriya-mohile/","tldr":"Led GAP70+, which showed a geriatric assessment cuts serious chemotherapy toxicity in older patients."}]}